Tags : UKI2S


MicrofluidX secures £1.4 million Seed investment led by UK Innovation

MicrofluidX raises £1.4m in seed funding to develop novel cell therapy bioprocessing technology London, UK, 20th April 2020 / MicrofluidX announces it has raised £1.4m in seed funding from leading seed investors UK Innovation & Science Seed Fund (UKI2S), Longwall Ventures and Moulton Goodies Limited with angel contributions from 88 Capital and Cambridge Angels. The Company will develop its […]Read More


Ikarovec secures £2.5 million seed funding led by UK Innovation

Ophthalmic gene therapy company Ikarovec launches with £2.5m seed funding Founded by UK Innovation & Science Seed Fund (UKI2S) with co-investment from LifeArc & Parkwalk to advance a diabetic macular edema gene therapy and other pipeline products Cambridge, February 5 2020: Ikarovec, which is developing novel gene therapies to treat major ophthalmic indications, has launched today […]Read More